These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?]. Oreziak A, Przybylski A. Kardiol Pol; 2009 Aug; 67(8):930-1. PubMed ID: 19885986 [No Abstract] [Full Text] [Related]
11. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing. Maass AH, Van Gelder IC. Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457 [No Abstract] [Full Text] [Related]
12. Cardiovascular implantable electronic devices in athletes. Do R, Patton KK. Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287 [Abstract] [Full Text] [Related]
13. Arrhythmic risk stratification in non-ischemic dilated cardiomyopathy: Where do we stand after DANISH? Dilaveris P, Antoniou CK, Gatzoulis KA. Trends Cardiovasc Med; 2017 Nov; 27(8):542-555. PubMed ID: 28709811 [Abstract] [Full Text] [Related]
16. An unusual case of impossible communication between an ICD and programmer. Attanasio P, Wutzler A, Huemer M, Parwani AS, Boldt LH, Haverkamp W, Blaschke F. J Cardiovasc Electrophysiol; 2015 Feb; 26(2):230. PubMed ID: 25257919 [No Abstract] [Full Text] [Related]
18. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S, Duehmke R, Providencia R, Marijon E, Boveda S, Virdee M, Heck P, Fynn S, Begley D, Grace A, Agarwal S. Europace; 2018 Jan 01; 20(1):89-96. PubMed ID: 28031276 [Abstract] [Full Text] [Related]